GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » Institutional Ownership

SMO Clinplus Co (SZSE:301257) Institutional Ownership : 22.78% (As of Jun. 01, 2024)


View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SMO Clinplus Co's institutional ownership is 22.78%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SMO Clinplus Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SMO Clinplus Co's Float Percentage Of Total Shares Outstanding is 0.00%.


SMO Clinplus Co Institutional Ownership Historical Data

The historical data trend for SMO Clinplus Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co Institutional Ownership Chart

SMO Clinplus Co Historical Data

The historical data trend for SMO Clinplus Co can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 10.19 10.19 10.16 10.16 10.16 23.37 22.78 22.78 22.78 22.78

SMO Clinplus Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


SMO Clinplus Co (SZSE:301257) Business Description

Traded in Other Exchanges
N/A
Address
No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.
Executives
Lai Chun Bao Director
Ma Lin Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines